{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"MannKind Corporation"},"Symbol":{"label":"Symbol","value":"MNKD"},"Address":{"label":"Address","value":"1 CASPER STREET,SUITE 300, DANBURY, Connecticut, 06810, United States"},"Phone":{"label":"Phone","value":"+1 818 661-5000"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler."},"CompanyUrl":{"label":"Company Url","value":"https://www.mannkindcorp.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Burkhard Blank","title":"Chief Medical Officer, EVP-Research & Development"},{"name":"Joseph Kocinsky","title":"Chief Technology Officer"},{"name":"Kevin Kaiserman","title":"Senior VP-Clinical Development & Medical Affairs"},{"name":"Lauren M. Sabella","title":"Chief Operating Officer & Executive Vice President"},{"name":"Michael E. Castagna","title":"Chief Executive Officer & Director"},{"name":"Sanjay Singh","title":"Executive Vice President-Technical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}